SPARKLE BYTE LTD 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-20 09:30 am Purchase | 2025-09-30 | 13D | CASI Pharmaceuticals, Inc. CASI | SPARKLE BYTE LTD | 1,019,852 5.000% | 1,019,852 (New Position) | Filing |